# The Veterinary Medicines (Amendment etc.) Regulations 2024, Regulation 47: Amendment to paragraph 26


In paragraph 26 (marketing authorisations in exceptional circumstances)—
(a) in sub-paragraph (1)(a), after “further data” insert “, taking into account the benefit of the immediate availability on the market of the veterinary medicinal product in comparison to the risks”;
(b) in sub-paragraph (1)(b), after “limited market” insert “, taking into account the benefit in relation to public or animal health of the availability of the product on the market in comparison to the risks.”;
(c) after sub-paragraph (1) insert—
“(1A) An exceptional marketing authorisation may be granted subject to such further conditions, including any restrictions, as the Secretary of State considers appropriate.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348258523/regulation/47 (the official version)
Page: https://openlegislation.uk/draft-veterinary-medicines-amendment-etc-regulations-2024/regulation-47
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.